NANETS congratulates Etay Ziv, MD, PhD of Memorial Sloan Kettering Cancer Center as the 2017 NANETS Clinical Investigator Scholarship recipient.  The NCIS award focuses on supporting a clinical project as well as the investigator's potential to make future clinical contributions to the neuroendocrine tumor field.  This award is in honor of Edda Gomez-Panzani, MD for her dedication and work on behalf of patients living with neuroendocrine tumors. 

The 2017 recipient, Dr. Etay Ziv, seeks to improve the outcome of patients undergoing liver directed therapy of pancreatic neuroendocrine tumor liver metastases.  Dr. Ziv will evaluate whether the molecular biomarker, DAXX mutation, is a predictor of poor response to liver-directed therapy.  This work has the potential to identify which patients will most likely benefit from treatment and to provide insight into why patients may or may not respond to treatment.   

IPSEN is proud to sponsor the continuation of Edda’s work on behalf of NET patients through this Clinical Investigator Scholarship. IPSEN Biopharmaceuticals supports this research scholarship in the form of a $100,000 grant directed to NANETS to administer over the course of the two year grant period. The NANETS Research Committee establishes the award criteria, reviews process, and independently selects the recipient.